Exact Mass: 587.2815812

Exact Mass Matches: 587.2815812

Found 437 metabolites which its exact mass value is equals to given mass value 587.2815812, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lipomycin

alpha-Lipomycin

C32H45NO9 (587.309416)

7-(3-((3-Acetylphenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic acid

7-{3-[(3-acetylphenoxy)methyl]-1,5-dimethyl-1H-pyrazol-4-yl}-3-[3-(naphthalen-1-yloxy)propyl]-1H-indole-2-carboxylic acid

C36H33N3O5 (587.2420088)

Glu-Ile-Leu-Asp-Val

4-Amino-4-[(1-{[1-({2-carboxy-1-[(1-carboxy-2-methylpropyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)-3-methylbutyl]-C-hydroxycarbonimidoyl}-2-methylbutyl)-C-hydroxycarbonimidoyl]butanoate

C26H45N5O10 (587.316627)

H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH

1-{2-[(2-{[2-({2-[(2-amino-1-hydroxyethylidene)amino]-5-carbamimidamido-1-hydroxypentylidene}amino)-1-hydroxyethylidene]amino}-3-carboxy-1-hydroxypropylidene)amino]-3-hydroxypropanoyl}pyrrolidine-2-carboxylate

C22H37N9O10 (587.2663262)

GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor.

Retaspimycin

({13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-[(prop-2-en-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(22),4,6,10,18,20-hexaen-9-yl}oxy)methanimidate

C31H45N3O8 (587.320649)

Ludaconitine

[(2R,3R,4R,5S,6S,8R,13R,14R,16S,17S,18R)-11-ethyl-5,8,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate

C32H45NO9 (587.309416)

Nothramicin

C30H37NO11 (587.2366492)

An anthracycline antibiotic isolated from the culture broth of Nocardia sp. MJ896-43F17. It exhibits significant antimycobacterial activity against several drug-resistant Mycobacterium smegmatis strains.

(1alpha,6alpha,14alpha,16beta)-20-ethyl-1,6,8-trihydroxy-16-methoxy-4-(methoxymethyl)aconitan-14-yl 3,4-dimethoxybenzoate|6-hydroxy-14-O-veratroylneoline|hemsleyaconitine B

C32H45NO9 (587.309416)

alpha-Lipomycin

C32H45NO9 (587.309416)

7beta-hydroxy-6beta-(3,4,5-trimethoxybenzoyloxy)-3alpha-(E)-(3,4,5-trimethoxycinnamoyloxy)tropane

C30H37NO11 (587.2366492)

6-[2-ethoxy-2-(2,4,5-trimethoxyphenyl)]ethyl-7,8-dimethoxy-5-methyl-2,3-methylenedioxy-5,6-dihydrobenzo[c]phenanthridine|buesgeniine

C34H37NO8 (587.2519042)

C23H41NO16

C23H41NO16 (587.2425226)

Sativanine E

C33H41N5O5 (587.3107536)

Ile Ile Asp Asp Ile

C26H45N5O10 (587.316627)

Gln Ala Gln Ile Glu

C24H41N7O10 (587.2914766)

His Val Phe Gly Glu

C27H37N7O8 (587.2703482000001)

Glu Gly Gln Arg Val

C23H41N9O9 (587.3027096000001)

Glu Leu Gly Lys Gln

C25H45N7O9 (587.32786)

Glu Gln Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C22H41N11O8 (587.3139426)

C28H37N5O7S (587.2413572)

SCH772984

(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide

C33H33N9O2 (587.2757078)

SCH772984 is a highly selective and ATP-competitive ERK inhibitor, with IC50s of 4 and 1 nM for ERK1 and ERK2, respectively. SCH772984 has antitumor activity in MAPK inhibitor-na?ve and MAPK inhibitor-resistant cells containing BRAF or RAS mutations[1].

TYR-D-ALA-GLY-PHE-MET

C28H37N5O7S (587.2413572)

gadolinium 2-ethylhexanoate

C24H45GdO6 (587.2457079999999)

Retaspimycin

C31H45N3O8 (587.320649)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

H-DL-Glu-DL-xiIle-DL-Leu-DL-Asp-DL-Val-OH

C26H45N5O10 (587.316627)

3-({1-[3-Carbamimidoyl-1-(4-carbamimidoyl-benzylcarbamoyl)-propylcarbamoyl]-2-methyl-butylsulfamoyl}-methyl)-benzoic acid

C27H37N7O6S (587.2525902)

[(2S)-1-oxo-1-[[(2S,10R,12S,14S)-12,16,19-trihydroxy-7,14,18-trimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methylamino]propan-2-yl]azanium

[(2S)-1-oxo-1-[[(2S,10R,12S,14S)-12,16,19-trihydroxy-7,14,18-trimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methylamino]propan-2-yl]azanium

C29H39N4O9+ (587.2716904)

[(4E,6Z,10E)-13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate

C31H45N3O8 (587.320649)

Dinoflagellate luciferin(1-)

(2s)-1-[(3s,7s,10s,13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

(2s)-1-[(3s,7s,10s,13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

C33H41N5O5 (587.3107536)

3α-(3,4,5-trimethoxy-cinnamoyloxy)-7β-(3,4,5-trimethoxybenzoyloxy)-6α-hydroxy-tropane

C30H37NO11 (587.2366492)

{"Ingredient_id": "HBIN007915","Ingredient_name": "3\u03b1-(3,4,5-trimethoxy-cinnamoyloxy)-7\u03b2-(3,4,5-trimethoxybenzoyloxy)-6\u03b1-hydroxy-tropane","Alias": "NA","Ingredient_formula": "C30H37NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21887","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,2r,3r,4r,5s,6s,8s,9s,10r,13s,16s,17s)-11-ethyl-5,8,17-trihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO9 (587.309416)

6-hydroxy-8-methyl-7-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate

C30H37NO11 (587.2366492)

(1-{[(1s)-1-[(1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl)trimethylazanium

(1-{[(1s)-1-[(1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl)trimethylazanium

[C30H43N4O8]+ (587.3080738)

(1r,2r,3r,4s,5s,6s,8s,9r,10s,13s,14r,16r,17r)-11-ethyl-5,8,14-trihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO9 (587.309416)

(1s,3s,5s,7r,10r,12s,14r,15s,18r,19r,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde

(1s,3s,5s,7r,10r,12s,14r,15s,18r,19r,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde

(1r,3r,4s,5r,8s,9r,10r,11r,14r,16s,17r,18r,19r)-4,10,19-tris(acetyloxy)-9,18-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl (2r)-2-methylbutanoate

C31H41NO10 (587.2730326000001)

(1s,3r,5s,7r,9r,10r,12r,14r,15s,18r,19r,22s,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde

(1s,3r,5s,7r,9r,10r,12r,14r,15s,18r,19r,22s,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde

C31H41NO8S (587.2552746000001)

(1s,2r,3r,4s,5r,6s,8r,9r,10r,12s,13r,16s,17s,18r)-11-ethyl-8,16,18-trihydroxy-6,12-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3,4-dimethoxybenzoate

C32H45NO9 (587.309416)

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13r,14r,16s,17s,18r)-11-ethyl-5,8,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C32H45NO9 (587.309416)

(1s,3r,5s,7r,9s,10r,12r,14r,15s,18r,19s,22s,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde

C31H41NO8S (587.2552746000001)